Wikidata

(Q63593973)

English

Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

clinical trial

In more languages

Statements

title
A Randomized, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of Amifampridine Phosphate in Ambulatory Patients With Spinal Muscular Atrophy (SMA) Type 3 (English)
0 references
medical condition
atrophy
0 references
muscular atrophy
0 references
country
Italy
0 references
start time
21 January 2019
0 references
end time
15 December 2019
0 references
number of participants
12
0 references
minimum age
6 year
0 references
maximum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63593973&oldid=2131412778"